Healthcare provider profile · identity verified

Constance Glynn Getsinger, FNP-C

Nurse Practitioner · STATESVILLE, NC · NPI 1700452000

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	79
Levothyroxine Sodium	Levothyroxine Sodium	235	45
Amlodipine Besylate	Amlodipine Besylate	231	49
Furosemide	Furosemide	200	53
Tamsulosin Hcl	Tamsulosin Hcl	181	29
Memantine Hcl	Memantine Hcl	174	19
Famotidine	Famotidine	160	22
Trazodone Hcl	Trazodone Hcl	159	30
Gabapentin	Gabapentin	139	41
Tramadol Hcl	Tramadol Hcl	128	44
Pravastatin Sodium	Pravastatin Sodium	114	17
Lorazepam	Lorazepam	113	35
Omeprazole	Omeprazole	105	24
Escitalopram Oxalate	Escitalopram Oxalate	96	17
Metformin Hcl	Metformin Hcl	92	19
Sertraline Hcl	Sertraline Hcl	92	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	91	28
Mirtazapine	Mirtazapine	91	15
Oxycodone Hcl	Oxycodone Hcl	91	33
Levetiracetam	Levetiracetam	86	15
Lisinopril	Lisinopril	79	19
Donepezil Hcl	Donepezil Hcl	78	suppressed
Metoprolol Succinate	Metoprolol Succinate	78	20
Pantoprazole Sodium	Pantoprazole Sodium	76	25
Potassium Chloride	Potassium Chloride	76	18
Divalproex Sodium	Divalproex Sodium	75	12
Losartan Potassium	Losartan Potassium	74	21
Eliquis	Apixaban	70	18
Clopidogrel	Clopidogrel Bisulfate	69	16
Valsartan	Valsartan	69	suppressed
Benztropine Mesylate	Benztropine Mesylate	68	suppressed
Simvastatin	Simvastatin	66	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	64	15
Alprazolam	Alprazolam	57	suppressed
Finasteride	Finasteride	56	suppressed
Montelukast Sodium	Montelukast Sodium	55	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	55	12
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	54	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	54	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	53	11
Pregabalin	Pregabalin	52	suppressed
Lacosamide	Lacosamide	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	21
Divalproex Sodium Er	Divalproex Sodium	44	suppressed
Duloxetine Hcl	Duloxetine Hcl	41	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	40	23
Allopurinol	Allopurinol	40	13
Doxycycline Hyclate	Doxycycline Hyclate	40	30
Xarelto	Rivaroxaban	39	suppressed
Cephalexin	Cephalexin	36	20
Hydralazine Hcl	Hydralazine Hcl	36	16
Spironolactone	Spironolactone	34	12
Lactulose	Lactulose	33	19
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Risperidone	Risperidone	32	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	17
Carvedilol	Carvedilol	30	15
Midodrine Hcl	Midodrine Hcl	29	suppressed
Olanzapine	Olanzapine	29	suppressed
Methadone Hcl	Methadone Hcl	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	18
Humalog Kwikpen U-100	Insulin Lispro	26	suppressed
Nystatin	Nystatin	26	16
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	18
Ranolazine Er	Ranolazine	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	21	suppressed
Haloperidol	Haloperidol	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Prednisone	Prednisone	18	suppressed
Topiramate	Topiramate	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Rexulti	Brexpiprazole	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	13
Clonazepam	Clonazepam	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	11
Myrbetriq	Mirabegron	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Torsemide	Torsemide	16	suppressed
Diazepam	Diazepam	15	suppressed
Glipizide	Glipizide	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Indapamide	Indapamide	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Ramipril	Ramipril	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Austedo	Deutetrabenazine	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Clobazam	Clobazam	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Nyamyc	Nystatin	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error